IFI-B · Prenylflavonoid Reduction Series

Specimen SS-F-BTR-849 // ZERO-BITTER · IFI-B

Prenylflavonoid · T2 Agrobacterium-A

Humulus lupulus

Hops

Tier IIPrenylflavonoid Reduction Series

Target Trait

46%

% reduction

Isoxanthohumol/8-PN reduction

Technical Specifications

SKU

SS-F-BTR-849

Genomic Edits

4

GC Content

45.2%

Construct Length

2,815 bp

Promoter System

35S CaMV / mas2

Expression System

T-DNA binary vector (pCAMBIA)

Host Strain

Agrobacterium tumefaciens EHA105

Receptor Target

TAS2R38 (suppression)

IFI Score

46

Pathway Edits

  • OMT1 O-methyltransferase RNAi reduces xanthohumol-to-isoxanthohumol Cope rearrangement substrate availability
  • PrenylT prenyltransferase RNAi limits prenylation of naringenin chalcone at the C-8 position
  • CHS2 chalcone synthase isoform modification reduces xanthohumol precursor pool from phloroglucyl-CoA

Key Interventions

OMT1 methyltransferase RNAiPrenylT C-8 prenylase silencingCHS2 chalcone reduction

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
46
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier II Humulus lupulus lines for brewery applications targeting soft bitterness profiles, cosmetic and nutraceutical hop extracts requiring controlled 8-PN content, and non-alcoholic hop-flavored beverages where prenylflavonoid bitterness would detract from consumer palatability.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?